LOCUS       QTZ43165                1239 aa            linear   VRL 20-APR-2021
DEFINITION  surface glycoprotein, partial [Severe acute respiratory syndrome
            coronavirus 2].
ACCESSION   QTZ43165
VERSION     QTZ43165.1
DBSOURCE    accession MW973533.1
KEYWORDS    .
SOURCE      Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  ORGANISM  Severe acute respiratory syndrome coronavirus 2
            Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
            Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
            Betacoronavirus; Sarbecovirus; Betacoronavirus pandemicum.
REFERENCE   1  (residues 1 to 1239)
  AUTHORS   Deng,X., Garcia-Knight,M.A., Khalid,M.M., Servellita,V., Wang,C.,
            Morris,M.K., Sotomayor-Gonzalez,A., Glasner,D.R., Reyes,K.R.,
            Gliwa,A.S., Reddy,N.P., Sanchez San Martin,C., Federman,S.,
            Cheng,J., Balcerek,J., Taylor,J., Streithorst,J.A., Miller,S.,
            Kumar,G.R., Sreekumar,B., Chen,P.Y., Schulze-Gahmen,U., Taha,T.Y.,
            Hayashi,J., Simoneau,C.R., McMahon,S., Lidsky,P.V., Xiao,Y.,
            Hemarajata,P., Green,N.M., Espinosa,A., Kath,C., Haw,M., Bell,J.,
            Hacker,J.K., Hanson,C., Wadford,D.A., Anaya,C., Ferguson,D.,
            Lareau,L.F., Frankino,P.A., Shivram,H., Wyman,S.K., Ott,M.,
            Andino,R. and Chiu,C.Y.
  TITLE     Transmission, infectivity, and antibody neutralization of an
            emerging SARS-CoV-2 variant in California carrying a L452R spike
            protein mutation
  JOURNAL   medRxiv (2021)
   PUBMED   33758899
  REMARK    Publication Status: Online-Only
REFERENCE   2  (residues 1 to 1239)
  AUTHORS   Chiu,C.Y., Deng,X., Wang,C., Servellita,V., Sotomayor-Gonzalez,A.,
            Wyman,S.K., Anaya,C., IDLB COVIDNet,C.D.P.H. and COVID Tracker
            Consortium,C.Z.B.
  TITLE     Direct Submission
  JOURNAL   Submitted (19-APR-2021) Laboratory Medicine, University of
            California, San Francisco, 185 Berry Street, Box 0134, San
            Francisco, CA 94107, USA
COMMENT     Method: conceptual translation.
FEATURES             Location/Qualifiers
     source          1..1239
                     /organism="Severe acute respiratory syndrome coronavirus
                     2"
                     /isolate="SARS-CoV-2/human/USA/CA-UCSF-UC849/2020"
                     /isolation_source="nasopharyngeal swab"
                     /host="Homo sapiens"
                     /db_xref="taxon:2697049"
                     /geo_loc_name="USA"
                     /collection_date="2020-12-22"
     Protein         <1..1239
                     /product="surface glycoprotein"
     Region          1..216
                     /region_name="CoV_Spike_S1_NTD"
                     /note="N-terminal domain of the S1 subunit of coronavirus
                     Spike (S) proteins; cl40465"
                     /db_xref="CDD:477362"
     Site            order(4,7..11,13,133,164..165,190,196,198,200)
                     /site_type="other"
                     /note="trimer interface [polypeptide binding]"
                     /db_xref="CDD:394949"
     Region          287..507
                     /region_name="SARS-CoV-2_Spike_S1_RBD"
                     /note="receptor-binding domain of the S1 subunit of severe
                     acute respiratory syndrome coronavirus 2 Spike (S)
                     protein; cd21480"
                     /db_xref="CDD:394827"
     Site            order(287,323,347..349,352,356,360,362,379,482..483,487)
                     /site_type="other"
                     /note="trimer interface [polypeptide binding]"
                     /db_xref="CDD:394827"
     Site            order(335..336,338,340,342..344,346,348,350..352,355..356,
                     358,394..396,481,483,485)
                     /site_type="other"
                     /note="cryptic epitope [polypeptide binding]"
                     /db_xref="CDD:394827"
     Site            order(383,412,415,419,421..422,441,452..453,455,459,462,
                     464,466..468,471)
                     /site_type="other"
                     /note="receptor binding site [polypeptide binding]"
                     /db_xref="CDD:394827"
     Site            404..474
                     /site_type="other"
                     /note="receptor binding motif"
                     /db_xref="CDD:394827"
     Region          509..1153
                     /region_name="CoV_Spike_S1-S2_S2"
                     /note="S1/S2 cleavage region and the S2 fusion subunit of
                     coronavirus spike (S) proteins; cl40439"
                     /db_xref="CDD:424070"
     Site            order(638,660..665,675)
                     /site_type="other"
                     /note="S1/S2 cleavage region"
                     /db_xref="CDD:411955"
     Site            764..772
                     /site_type="other"
                     /note="fusion peptide"
                     /db_xref="CDD:411955"
     Site            782..799
                     /site_type="other"
                     /note="internal fusion peptide"
                     /db_xref="CDD:411955"
     Region          884..949
                     /region_name="heptad repeat 1"
                     /note="heptad repeat 1 [structural motif]"
                     /db_xref="CDD:411955"
     CDS             1..1239
                     /gene="S"
                     /coded_by="MW973533.1:<21630..25349"
ORIGIN      
        1 gvyypdkvfr ssvlhstqdl flpffsnvtw fhaihvsgtn gtkrfdnpvl pfndgvyfas
       61 teksniirgw ifgttldskt qsllivnnat nvvikvcefq fcndpflgvy yhknnkswme
      121 sefrvyssan nctfeyvsqp flmdlegkqg xxxxxxxxxx xxxxxxxxxx xxxxxxxxxr
      181 dlpqgfsale plvdlpigin itrfqtllal hrsyltpgxx xxxxxxxxxx xxxxxxxxxx
      241 xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxqpte sivrfpnitn
      301 lcpfgevfna trfasvyawn rkrisncvad ysvlynsasf stfkcygvsp tklndlcftn
      361 vyadsfvirg devrqiapgq tgkiadynyk lpddftgcvi awnsnnldsk vggnynylyr
      421 lfrksnlkpf erdisteiyq agstpcngve gfncyfplqs ygfqptngvg yqpyrvvvls
      481 fellhapatv cgpkkstnlv knkcvnfnfn gltgtgvlte snkkflpfqq fgrdiadttd
      541 avrdpqtlei lditpcsfgg vsvitpgtnt snqvavlyqg vnctevpvai hadqltptwr
      601 vystgsnvfq tragcligae hvnnsyecdi pigagicasy qtqtnsprra rsvasqsiia
      661 ytmslgaens vaysnnsiai ptnftisvtt eilpvsmtkt svdctmyicg dstecsnlll
      721 qygsfctqln raltgiaveq dkntqevfaq vkqiyktppi kdfggfnfsq ilpdpskpsk
      781 rsfiedllfn kvtladagfi kqygdclgdi aardlicaqk fngltvlppl ltdemiaqyt
      841 sallagtits gwtfgagaal qipfamqmay rfngigvtqn vlyenqklia nqfnsaigki
      901 qdslsstasa lgklqdvvnq naqalntlvk qlssnfgais svlndilsrl dkveaevqid
      961 rlitgrlqsl qtyvtqqlir aaeirasanl aatkmsecvl gqskrvdfcg kgyhlmsfpq
     1021 saphgvvflh vtyvpaqekn fttapaichd gkahfpregv fvsngthwfv tqrnfyepqi
     1081 ittdntfvsg ncdvvigivn ntvydplqpe ldsfkeeldk yfknhtspdv dlgdisgina
     1141 svvniqkeid rlnxxxxxxx xxxxxxxxxx xxeqyikwpw yiwlgfiagl iaivmvtiml
     1201 ccmtsccscl kgccscgscc kfdeddsepv lkgvklhyt
//

